Abl imatinib. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy20

K562 Cells Philadelphia Chromosome Cell Line, Tumor Chromosomes, Human, Pair 9 Hematopoietic Stem Cells Chromosomes, Human, Pair 22 Neoplastic Stem Cells Tumor Cells, Cultured Bone Marrow Cell Line Myeloid Progenitor Cells HL-60 Cells Cells, Cultured Bone Marrow Cells Cell Line, Transformed Palate, Hard Clone Cells Stromal Cells Interstitial Cells of Cajal Blood Cells

Organisms6

Mice, Nude Papio anubis Mice, SCID Abelson murine leukemia virus Retroviridae Mice, Inbred BALB C

Diseases44

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Leukemia, Myeloid, Chronic-Phase Blast Crisis Philadelphia Chromosome Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Gastrointestinal Neoplasms Hypereosinophilic Syndrome Leukemia, Myeloid, Accelerated Phase Precursor Cell Lymphoblastic Leukemia-Lymphoma Neoplasm, Residual Dermatofibrosarcoma Disease Progression Muscle Cramp Fibromatosis, Aggressive Mastocytosis, Systemic Leukemia Hypopigmentation Translocation, Genetic Cell Transformation, Neoplastic Recurrence Abetalipoproteinemia Pregnancy Complications, Neoplastic Lichenoid Eruptions Neoplasm Recurrence, Local Chordoma Scleroderma, Diffuse Leukemia, Myeloid Chromosome Aberrations Cecal Neoplasms Fibrosis Scleroderma, Systemic Disease Models, Animal Gynecomastia Leukemia, Experimental Hypophosphatemia Splenomegaly Edema Mastocytosis Neutropenia Neoplasm Metastasis Testicular Hydrocele Primary Myelofibrosis Myeloproliferative Disorders

Chemicals and Drugs72

Benzamides Piperazines Pyrimidines Fusion Proteins, bcr-abl Proto-Oncogene Proteins c-abl Antineoplastic Agents Protein Kinase Inhibitors Proto-Oncogene Proteins c-kit Protein-Tyrosine Kinases Receptor, Platelet-Derived Growth Factor alpha Oncogene Proteins v-abl Thiazoles Proto-Oncogene Proteins c-bcr Organic Cation Transporter 1 Receptors, Platelet-Derived Growth Factor Harringtonines Interferon-alpha Enzyme Inhibitors src-Family Kinases Pyrroles STAT5 Transcription Factor Oncogene Proteins, Fusion Proto-Oncogene Proteins c-crk RNA, Messenger Cytarabine Biomarkers, Pharmacological RNA, Neoplasm Hydroxyurea Antigens, CD34 Indoles Proto-Oncogene Proteins c-sis mRNA Cleavage and Polyadenylation Factors Platelet-Derived Growth Factor Adaptor Proteins, Signal Transducing Neoplasm Proteins P-Glycoprotein Proto-Oncogene Proteins Phosphotyrosine Oncogene Proteins Milk Proteins Aniline Compounds Tyrosine Pyridines Stem Cell Factor Pyridones Quinolines Benzenesulfonates Phenylurea Compounds Orosomucoid Proto-Oncogene Proteins c-akt Niacinamide ATP-Binding Cassette Transporters Phenyl Ethers Interleukin-3 Nitriles Tumor Markers, Biological Janus Kinase 2 Cytochrome P-450 CYP3A Phosphatidylinositol 3-Kinases RNA, Small Interfering Phthalazines Receptor, Macrophage Colony-Stimulating Factor Drugs, Investigational raf Kinases DNA-Binding Proteins Lactams, Macrocyclic Aclarubicin Recombinant Fusion Proteins Proto-Oncogene Proteins c-bcl-2 Farnesyltranstransferase Benzoquinones Rifabutin

Analytical, Diagnostic and Therapeutic Techniques and Equipment60

Cytogenetic Analysis Treatment Outcome Remission Induction Disease-Free Survival Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols In Situ Hybridization, Fluorescence Treatment Failure Reverse Transcriptase Polymerase Chain Reaction Inhibitory Concentration 50 Survival Analysis Survival Rate Drug Monitoring Salvage Therapy Prognosis DNA Mutational Analysis Drug Approval Follow-Up Studies Blotting, Western Administration, Oral Drug Screening Assays, Antitumor Clinical Trials, Phase II as Topic Clinical Trials as Topic Withholding Treatment Early Termination of Clinical Trials Kaplan-Meier Estimate Karyotyping Polymerase Chain Reaction Hematopoietic Stem Cell Transplantation Transplantation, Homologous Models, Economic Xenograft Model Antitumor Assays Immunohistochemistry Neoadjuvant Therapy Transfection Stem Cell Transplantation Clinical Trials, Phase III as Topic Therapies, Investigational Models, Molecular Combined Modality Therapy Retrospective Studies Flow Cytometry Immunoprecipitation Tumor Stem Cell Assay Chromatography, High Pressure Liquid Positron-Emission Tomography Disease Models, Animal Chemotherapy, Adjuvant Maximum Tolerated Dose Clinical Trials, Phase I as Topic Leukemia, Experimental Drug Evaluation, Preclinical Molecular Targeted Therapy Gene Expression Profiling Gene Knockdown Techniques Mass Spectrometry Immunoblotting Blood Cell Count Bone Marrow Transplantation Neoplasm Transplantation

Phenomena and Processes41

Genes, abl Drug Resistance, Neoplasm Philadelphia Chromosome Gene Expression Regulation, Leukemic Mutation Phosphorylation Apoptosis Dose-Response Relationship, Drug Cell Proliferation Signal Transduction Chromosomes, Human, Pair 9 Time Factors Genes, sis Drug Synergism src Homology Domains Inhibitory Concentration 50 Chromosomes, Human, Pair 22 Translocation, Genetic Cell Survival Protein Structure, Tertiary Gene Expression Regulation, Neoplastic Point Mutation Enzyme Activation Cell Division Drug Interactions Exons Protein Binding Cell Cycle Chromosome Aberrations Transfection Base Sequence Down-Regulation Amino Acid Sequence Drug Resistance Gene Rearrangement Oncogenes Maximum Tolerated Dose Cell Growth Processes Genes, fms RNA Interference Blood Cell Count

Disciplines and Occupations2

Cytogenetics Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Drug Approval United States Food and Drug Administration

Technology, Industry, Agriculture1

Information Science4

Survival Rate Molecular Sequence Data Base Sequence Amino Acid Sequence

Health Care16

Treatment Outcome Disease-Free Survival Treatment Failure Survival Analysis Survival Rate Follow-Up Studies Clinical Trials, Phase II as Topic Clinical Trials as Topic Withholding Treatment Early Termination of Clinical Trials Kaplan-Meier Estimate Models, Economic Clinical Trials, Phase III as Topic Retrospective Studies Clinical Trials, Phase I as Topic United States Food and Drug Administration

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care

Benzamides Piperazines Pyrimidines Genes, abl Leukemia, Myelogenous, Chronic, BCR-ABL Positive Fusion Proteins, bcr-abl Gastrointestinal Stromal Tumors Proto-Oncogene Proteins c-abl Antineoplastic Agents Protein Kinase Inhibitors Leukemia, Myeloid, Chronic-Phase Proto-Oncogene Proteins c-kit Drug Resistance, Neoplasm K562 Cells Protein-Tyrosine Kinases Receptor, Platelet-Derived Growth Factor alpha Blast Crisis Oncogene Proteins v-abl Philadelphia Chromosome Thiazoles Cytogenetic Analysis Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Proto-Oncogene Proteins c-bcr Gastrointestinal Neoplasms Hypereosinophilic Syndrome Treatment Outcome Remission Induction Leukemia, Myeloid, Accelerated Phase Organic Cation Transporter 1 Gene Expression Regulation, Leukemic Mutation Cell Line, Tumor Receptors, Platelet-Derived Growth Factor Precursor Cell Lymphoblastic Leukemia-Lymphoma Phosphorylation Disease-Free Survival Apoptosis Harringtonines Dose-Response Relationship, Drug Interferon-alpha Cell Proliferation Enzyme Inhibitors Neoplasm, Residual Signal Transduction Chromosomes, Human, Pair 9 Dermatofibrosarcoma Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols src-Family Kinases Pyrroles Disease Progression Time Factors Genes, sis Drug Synergism In Situ Hybridization, Fluorescence Treatment Failure Muscle Cramp Fibromatosis, Aggressive Reverse Transcriptase Polymerase Chain Reaction STAT5 Transcription Factor src Homology Domains Mastocytosis, Systemic Leukemia Inhibitory Concentration 50 Oncogene Proteins, Fusion Proto-Oncogene Proteins c-crk Hematopoietic Stem Cells Survival Analysis Chromosomes, Human, Pair 22 Survival Rate Drug Monitoring RNA, Messenger Hypopigmentation Salvage Therapy Prognosis Cytarabine Neoplastic Stem Cells Tumor Cells, Cultured Translocation, Genetic Cytogenetics Cell Transformation, Neoplastic Biomarkers, Pharmacological DNA Mutational Analysis RNA, Neoplasm Hydroxyurea Drug Approval Antigens, CD34 Indoles Recurrence Cell Survival Proto-Oncogene Proteins c-sis mRNA Cleavage and Polyadenylation Factors Platelet-Derived Growth Factor Follow-Up Studies Bone Marrow Cell Line Blotting, Western Administration, Oral Adaptor Proteins, Signal Transducing Neoplasm Proteins

No FAQ available that match "abl imatinib"